Bioanalytical Microchips Based on Integrated, Application Tailored Monolithic Modules

基于集成、定制应用单片模块的生物分析微芯片

• 批准号: DP0666121
• 负责人: Prof Emily Hilder
• 金额: $ 12.45万
• 依托单位: University of Tasmania
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2006
• 资助国家: 澳大利亚
• 起止时间: 2006-03-01 至 2009-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP0666121
• 关键词: Bioanalytical; Microchips; Based; Integrated; Application

Microfluidic devices offer substantial advantages over current technology, in terms of speed, cost of analysis, portability, operator simplicity and safety. Integrating multiple analytical processes within a simple and reliable portable device will lead to application in a range of areas, from pharmacology to therapeutic drug monitoring, proteomic and metabolomic screening for disease diagnosis and drug development, and also for performing clinical diagnostics in a rural area. This will significantly impact on the quality of life of the Nation as a whole, not only due to expedient diagnosis and treatment which has obvious health benefits, but also in the considerable financial benefits that result from early and efficient treatment.

在速度，分析成本，可移植性，操作员的简单性和安全性方面，微流体设备与当前技术相比具有很大的优势。将多个分析过程整合在简单可靠的便携式设备中，将导致在从药理学到治疗性药物监测，蛋白质组学和代谢组筛查疾病诊断和药物开发以及在农村地区进行临床诊断的一系列地区应用。这将对整个国家的生活质量产生重大影响，这不仅是由于具有明显健康益处的优势诊断和治疗，而且对早期和高效治疗所带来的可观经济利益。